Category: Oncology

Pleural Mesothelioma (Drug Study-2) Targeted therapy: Targeted therapy drugs, such as bevacizumab and sorafenib, aim to block specific molecules involved in cancer growth and progression. These drugs are being evaluated in clinical trials to determine their effectiveness in treating pleural mesothelioma.

Pleural mesothelioma (Drug Study-1) Pleural mesothelioma, a cancer affecting the lining of the lungs, often develops due to exposure to asbestos. Research into treatments for this aggressive disease is ongoing, and drug studies play a crucial role in finding effective therapies. Several drugs and treatment approaches are being investigated in clinical trials for pleural mesothelioma. […]

Pleural Mesothelioma (PET Scan-1) Positron emission tomography (PET) scan is a powerful imaging technique used in the diagnosis, staging, and monitoring of various cancers, including pleural mesothelioma. PET scans are advanced imaging tools that provide detailed information about the metabolic activity of tissues, helping clinicians to identify the extent of disease spread, plan treatment strategies […]

Pleural Mesothelioma (Evidence Based Management-8) Long-Term Monitoring and Surveillance: After completing initial treatment, patients with pleural mesothelioma require regular follow-up visits and surveillance imaging to monitor for disease recurrence, assess treatment response, and address any emerging issues or complications.

Pleural Mesothelioma (Evidence Based Management-7) Symptom Management and Supportive Care: Palliative care and supportive interventions play a crucial role in managing symptoms, addressing treatment-related side effects, and improving the overall quality of life for patients with pleural mesothelioma. This may include pain management, respiratory support, nutritional support, psychosocial support, and end-of-life care.

Pleural Mesothelioma (Evidence Based Management-6) Clinical Trials: Participation in clinical trials is encouraged for patients with pleural mesothelioma, as it offers access to investigational treatments and contributes to the advancement of knowledge and treatment options for the disease. Clinical trials may evaluate new drugs, treatment combinations, or innovative approaches such as immunotherapy or gene therapy.